Physician profile
Jeffrey D Mendelson
NPI 1396735106
$6,720.57
in general payments reported to CMS, 2019-2025
19 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $35.85 · 2021: $494 · 2022: $1,457 · 2023: $182 · 2024: $3,437 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,299 · Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,298.79 |
| Food and Beverage | $1,329.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,854.66 | 2019-2025 | Persona, Oxford |
| Stryker Corporation | $304.22 | 2023-2025 | Actishield, Blueprint Patient Specific Instrumentation |
| Bioness INC | $137.46 | 2021 | |
| Dynasplint Systems INC. | $69.04 | 2022 | |
| Medtronic, INC. | $51.81 | 2025 | Synchromedii |
| Lundbeck LLC | $51.44 | 2022-2023 | Vyepti |
| Horizon Therapeutics Plc | $36.39 | 2020-2021 | |
| Treace Medical Concepts, INC. | $28.37 | 2025 | |
| Si-Bone, INC. | $25.38 | 2025 | |
| Janssen Biotech, INC. | $22.16 | 2022 | |
| Heron Therapeutics, INC. | $20.34 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.08 | 2022 | |
| Pinnacle, INC | $19.55 | 2024 | |
| Paratek Pharmaceuticals, INC. | $16.46 | 2024 | Nuzyra |
| Convatec INC. | $15.15 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.79 | 2020 | |
| Linvatec Corporation | $12.50 | 2021 | |
| Endo Pharmaceuticals INC. | $11.97 | 2020 | |
| Novartis Pharmaceuticals Corporation | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Mendelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.